Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
36,723,457
-
Share change
-
-1,194,257
-
Total reported value
-
$33,069,178
-
Price per share
-
$0.89
-
Number of holders
-
25
-
Value change
-
-$1,035,149
-
Number of buys
-
9
-
Number of sells
-
12
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q2 2018
As of 30 Jun 2018,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,723,457 shares.
The largest 10 holders included
BVF INC/IL, Senvest Management, LLC, ORBIMED ADVISORS LLC, MORGAN STANLEY, Opaleye Management Inc., Benchmark Capital Advisors, SUSQUEHANNA INTERNATIONAL GROUP, LLP, COMMONWEALTH EQUITY SERVICES, LLC, NEXT Financial Group, Inc, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.